Enhanced -Synuclein Expression in Human Neurodegenerative Diseases: Pathogenetic and Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|10|5|476-482

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.10, Iss.5, 2009-10, pp. : 476-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

#945;-Synuclein Misfolding and Neurodegenerative Diseases

By  

Current Protein and Peptide Science, Vol. 9, Iss. 5, 2008-10 ,pp. : 507-540

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics

By Pong Kevin  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 127-139

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases

By Drew K.L.   Rice M.E.   Kuhn T.B.   Smith M.A.  

Free Radical Biology and Medicine, Vol. 31, Iss. 5, 2001-09 ,pp. : 563-573

Elsevier

Access to resources Recommend Favorite

Editorial (Hot Topic: Therapeutic Targets in Neurodegenerative Diseases)

By  

Current Enzyme Inhibition, Vol. 9, Iss. 1, 2013-01 ,pp. : 1-2

Bentham Science Publishers

Access to resources Recommend Favorite

LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases

By Xu Pei   Li Dabing   Tang Xiaotong   Bao Xiaohang   Huang Jing   Tang Yongping   Yang Yang   Xu Haiwei   Fan Xiaotang  

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 715-728

Humana Press, Inc

Access to resources Recommend Favorite